Research Article
Volume 9 Issue 2 - 2021
Evaluation of Lamotrigine in Bipolar Depression: Focus on Psychosocial Factors Affecting Response to Treatment and Patient Satisfaction with Medication
Trishala Punjabi1, Shikha Sood2*, Hemant Tiwari3, Hansal Bhachech4, Utkarsh Kachhia1 and Supriya Malhotra6
1IIIrd MBBS Student, Smt. NHL Municipal Medical College, Ahmedabad, Gujarat, India
2Associate Professor, Department of Pharmacology, Smt. NHL Municipal Medical College, Ahmedabad, Gujarat, India
3Assistant Professor (Biostatistics), Department of Community Medicine, Smt. NHL Municipal Medical College, Ahmedabad, Gujarat, India
4M.D. Psychiatry, Consultant Psychiatrist at Happy Minds Clinic, Ahmedabad, Gujarat, India
5Professor and Head, Department of Pharmacology, Smt. NHL Municipal Medical College, Ahmedabad, Gujarat, India
*Corresponding Author: Shikha Sood, Associate Professor, Department of Pharmacology, Smt. NHL Municipal Medical College, Ahmedabad, Gujarat, India.
Received: September 10, 2020; Published: January 29, 2021


Introduction:  Bipolar disorder is a difficult to treat condition where mood stabilizers play a major role along with adjunctive therapy.

Objectives: Objectives of this study were to evaluate Lamotrigine in the treatment of Bipolar depression; to assess the role of psychosocial factors in modifying the response to treatment and also to evaluate treatment satisfaction with medication.

Methodology: Patients diagnosed with bipolar disorder receiving Lamotrigine with or without other mood stabilizers were administered Hamilton rating scale for depression (HAM-D) at week 0 and week 4. The HAM-D scores were compared to evaluate efficacy. Patients were also administered a Trauma Experience Checklist (TEC) at week 0 to report whether any traumatizing event existed in their life that could modify response to treatment. These events were classified as acute, chronic or no stressor. HAM-D scores in patients with different stressors were evaluated to find out if any correlation existed between stressors and response to treatment. A questionnaire regarding patient satisfaction with treatment (TSQM version 1.4) was administered at week 4. Mann-Whitney U test and Wilcoxon Rank Sum tests were used for calculating the statistics and p value <0.05 was considered significant.

Result: 37 patients diagnosed with bipolar disorder receiving Lamotrigine 200mg/day were enrolled in the study.  13 patients received other mood stabilizers like lithium or valproate. Adjunctive drugs included hypnotics, antipsychotics, antidepressants and miscellaneous drugs. There was significant improvement in HAM-D scores in patients with mild, moderate and severe depression. There was significant improvement in depression associated parameters like depressed mood, suicidal thoughts, anxiety, insomnia, somatic symptoms and work and activities. Patients with no stressors and acute stressors showed a greater response to therapy as compared to chronic stressors. In them the response was significant. Patient satisfaction with treatment was 93% both in euthymic patients and patients with depression.

Conclusion: lamotrigine is efficacious in the treatment of Bipolar disorder; both for maintenance of euthymia and improvement of depression. Presence of chronic stressors in patient’s life have a detrimental effect on response to treatment as compared to no stressors and acute stressors. We found patient satisfaction with treatment of about 93%.

Keywords: Lamotrigine; Bipolar Depression; Patient Satisfaction With Treatment; Trauma Experience


  1. Grande I., et al. “Bipolar disorder”. Lancet10227 (2016): 1561-1572.
  2. Podawiltz A. “A review of current bipolar disorder treatment guidelines”. The Journal of Clinical Psychiatry 3 (2012): e12.
  3. Bowden CL. “Treatment strategies for bipolar depression”. The Journal of Clinical Psychiatry 5 (2010): e10.
  4. Prabhavalkar Kedar S., et al. “Management of bipolar depression with lamotrigine: an antiepileptic mood stabilizer”. Frontiers in Pharmacology 6 (2015): 242.
  5. Reid JG., et al. “Lamotrigine in psychiatric disorders”. The Journal of Clinical Psychiatry 7 (2013): 675-684.
  6. Aldinger Fanny and Schulze Thomas G. “Environmental factors, life events, and trauma in the course of bipolar disorder”. Psychiatry and Clinical Neurosciences 1 (2017): 6-17.
  7. Gershon A., et al. “Chronic Stressors and Trauma: Prospective Influences on the Course of Bipolar Disorder”. Psychological Medicine 12 (2013): 2583-2592.
  8. Hamilton M. “A rating scale for depression”. Journal of Neurology, Neurosurgery, and Psychiatry 23 (1960): 56-62.
  9. Nijenhuis ERS., et al. “The psychometric characteristics of the Traumatic Experiences Questionnaire (TEC): First findings among psychiatric outpatients”. Clinical Psychology and Psychotherapy3 (2002): 200-210.
  10. Vermersch Patrick., et al. “Measuring treatment satisfaction in MS: Is the Treatment Satisfaction Questionnaire for Medication fit for purpose?” Multiple Sclerosis4 (2017): 604-613.
  11. Diflorio Arianna and Jones Ian. “Is sex important? Gender differences in Bipolar disorder”. International Review of Psychiatr 5 (2010): 437-452.
  12. Rihmer Z., et al. “Treatment of bipolar disorder with lamotrigine -- relapse rate and suicidal behavior during 6-month follow-up”. Neuropsychopharmacology Hung1 (2015): 7-13.
  13. Goodwin GM., et al. “A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder”. The Journal of Clinical Psychiatry 3 (2004): 432-441.
  14. Ketter TA and Calabrese JR. “Stabilization of mood from below versus above baseline in bipolar disorder: a new nomenclature”. The Journal of Clinical Psychiatr 2 (2002): 146-151.
  15. Bowden CL., et al. “Lamotrigine in the treatment of bipolar depression”. European Neuropsychopharmacology 4 (1999): S113-S117.
  16. Dienes KA., et al. “The stress sensitization hypothesis: understanding the course of bipolar disorder”. Journal of Affective Disorders 1-3 (2006): 43-49.
  17. Gershon A., et al. “Chronic Stressors and Trauma: Prospective Influences on the Course of Bipolar Disorder”. Psychological Medicine 12 (2014): 2583-2592.
  18. Miklowitz DJ., et al. “Family Factors and the Course of Bipolar Affective Disorder”. Archives Of General Psychiatry 3 (1988): 225-231.
Citation: Shikha Sood., et al. “Evaluation of Lamotrigine in Bipolar Depression: Focus on Psychosocial Factors Affecting Response to Treatment and Patient Satisfaction with Medication”. EC Pharmacology and Toxicology 9.2 (2021): 34-44.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

April Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the April issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for upcoming Issue

Ecronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before May 04, 2021.

Certificate of Publication

Ecronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

Ecronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.

Immediate Assistance

The prime motto of this team is to clarify all the queries without any delay or hesitation to avoid the inconvenience. For immediate assistance on your queries please don't hesitate to drop an email to